54 371 Pill - orange round, 7mm
Pill with imprint 54 371 is Orange, Round and has been identified as Zolpidem Tartrate 5 mg. It is supplied by Roxane Laboratories, Inc.
Zolpidem is used in the treatment of Insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for 54 371
Zolpidem Tartrate
- Imprint
- 54 371
- Strength
- 5 mg
- Color
- Orange
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Roxane Laboratories, Inc.
- National Drug Code (NDC)
- 00054-0086 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
FD&C Blue No. 2,
FD&C Red No. 40,
FD&C Yellow No. 6,
hypromelloses,
ferric oxide red,
lactose anhydrous,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polysorbate 80,
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Related images for "54 371"
More about zolpidem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,047)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- Breastfeeding
- En español
Patient resources
- Zolpidem drug information
- Zolpidem (Oral) (Advanced Reading)
- Zolpidem (Oromucosal, Sublingual) (Advanced Reading)
- Zolpidem Extended-Release Tablets
- Zolpidem Oral Spray
Other brands
Ambien, Ambien CR, Zolpimist, Intermezzo, Edluar
Professional resources
- Zolpidem monograph
- Zolpidem (FDA)
- Zolpidem Capsule (FDA)
- Zolpidem Extended Release (FDA)
- Zolpidem Sublingual (FDA)
Other brands
Ambien, Ambien CR, Zolpimist, Intermezzo, Edluar
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
